Home dialysis traces back to the same inventor who later built the Segway. Dean Kamen invented the first wearable infusion pump and, at DEKA Research, the automated peritoneal dialysis technology behind Baxter's home cycler, a machine that lets a patient perform dialysis at home while software governs the delicate cycle of filling, dwelling, and draining dialysate. In Baxter Healthcare Corp. and DEKA Products Limited Partnership v. Fresenius Medical Care Holdings, Inc., in the U.S. District Court for the Northern District of California (No. C 07-01359 PJH), Baxter and DEKA asserted nine patents, owned by Baxter or licensed from DEKA, against Fresenius's Liberty Cycler peritoneal dialysis system.
A patent case with a software-quality attack
The dispute was a patent infringement case, but part of the plaintiffs' presentation reached beyond claim charts and into the quality of Fresenius's engineering. Their software expert opined that the embedded software and design of the accused Fresenius cycler were of poor quality. That kind of opinion is not an element of infringement, because claims either read on the accused product or they do not. What it does is supply an atmospheric theme: the suggestion that a defendant whose engineering looks sloppy must have copied, which supports a plaintiff's copying and willfulness narrative and can color a jury's view of the accused product in a close case.
Left unanswered, a "their engineering is shoddy, so they must have taken ours" theme is exactly the kind of impression that moves juries. Rebutting it is not throwaway work. That is why Fresenius brought in Barr Group.
Software quality and safety experts for the defense
Barr Group served on behalf of Fresenius, the defendant, providing embedded software expertise focused on the quality and safety of the dialysis cycler's control software. The engagement was, in significant part, a rebuttal of the plaintiffs' software expert: examining the Fresenius cycler's software directly, evaluating how it was actually engineered against the expectations for a safety-critical medical device, and answering the credibility attack on that engineering. Michael Barr prepared an expert report and was deposed in 2009. The work drew on the discipline Barr Group brings to every safety-critical embedded system: reading the firmware as it actually runs, assessing fault handling and safe-state design, and tying every conclusion to the code and the record rather than to impression. The specific findings remain confidential to the matter.
Litigation outcomes
The case ended in a complete defense verdict for Fresenius. Over the course of the litigation, Fresenius removed certain functionality from the Liberty Cycler, seven of the nine asserted patents were stayed or dismissed, and in 2010 the jury found that neither of the two patents that reached trial was infringed. In 2011 the court denied Baxter's post-trial motions, and no appeal disturbed the result (a matter of public record, including Baxter's own securities filings). Barr Group's rebuttal of the software-quality attack supported that successful defense.
Because the jury found no infringement, the questions of willfulness and damages, where a plaintiff's disparagement of a defendant's engineering does its work, were never reached. The theme that Fresenius's software was poor quality never translated into a single finding of infringement, willfulness, or damages. It died with the verdict, which is the cleanest summary of how that part of the fight resolved.
Learn more about Barr Group's expert witness services.